Today: 7 February 2026
Subscribe
Browse Category

Stock Market News 23 January 2026

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences (REVB) stock ticks up premarket after FDA lays out Gemini trial path

Revelation Biosciences shares rose about 2% premarket after an SEC filing showed FDA agreement on a single adaptive Phase 2/3 trial for its Gemini program in acute kidney injury. The company said strong results from roughly 300 patients could support a U.S. approval filing. Shares last traded near $0.85. Investors remain focused on trial timing and the firm’s $12.7 million cash position.
23 January 2026
··
US economic calendar today: Intel slides, Wall Street futures dip ahead of PMI and Michigan sentiment

US economic calendar today: Intel slides, Wall Street futures dip ahead of PMI and Michigan sentiment

U.S. stock futures slipped early Friday after Intel shares plunged 13.6% on a weak outlook. At 5:57 a.m. ET, S&P 500 E-minis were down 0.23%, Nasdaq 100 E-minis fell 0.35%, and Dow E-minis dropped 0.24%. Investors await key PMI data and the Michigan sentiment index later this morning. Intuitive Surgical rose 3.7% premarket after beating earnings estimates.
23 January 2026
··
Intel stock plunges in premarket, putting AI chip stocks and prices in play ahead of Big Tech earnings

Intel stock plunges in premarket, putting AI chip stocks and prices in play ahead of Big Tech earnings

Intel fell 13.6% in premarket trading after warning of supply shortages for AI data-center chips, erasing up to $31 billion in market value. Nasdaq 100 futures dropped 0.35% by 5:57 a.m. ET. Investors are watching a packed earnings week for signs that AI spending is translating into profit growth. Memory-chip prices are rising as AI infrastructure strains supply chains.
23 January 2026
··
UK stock market today: FTSE 100 slips as upbeat UK data meets rate-cut doubts; Babcock, C&C move

UK stock market today: FTSE 100 slips as upbeat UK data meets rate-cut doubts; Babcock, C&C move

The FTSE 100 fell 0.13% to 10,136.43 on Friday, reversing early gains as strong UK retail sales and a jump in business activity fueled speculation the Bank of England may delay rate cuts. Retail sales rose 0.4% in December, beating forecasts, while the UK Composite PMI hit 53.9, its highest since April 2024. Babcock shares slipped 1.2% after its CEO announced plans to retire. C&C Group dropped 9.6% on a profit warning.
23 January 2026
····
CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

CRISPR Therapeutics stock in focus as shares cool premarket after 11% surge and CEO sale filing

CRISPR Therapeutics shares slipped 0.5% to $60.51 in premarket trading Friday after CEO Samarth Kulkarni sold 90,000 shares for about $5.2 million under a preset plan, an SEC filing showed. The stock had surged 11.1% Thursday on heavy volume. Options trading spiked, with focus on April $90 calls. Bank of America trimmed its price target to $89 but kept a Buy rating.
23 January 2026
··
Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher

Atul Q3 results: profit jumps 40% but labour-code costs bite; shares end higher

Atul Ltd shares rose 1.03% to 5,833.25 rupees after reporting a 40% year-on-year profit jump to 163.54 crore rupees for the December quarter, with revenue up 11% to 1,573.62 crore. Operating expenses climbed 2.9% from the previous quarter, and employee benefit costs surged due to a 41.35 crore rupee provision for new labour codes. Indian stocks closed lower, with the Nifty 50 down 0.95%.
23 January 2026
··
CSGS stock price inches from NEC’s $80.70 deal — what traders watch before the Jan. 30 vote

CSGS stock price inches from NEC’s $80.70 deal — what traders watch before the Jan. 30 vote

CSG Systems closed Thursday at $79.83, just below NEC’s $80.70-per-share cash offer ahead of a Jan. 30 shareholder vote on the deal. The stock hit a 52-week high of $80.28 during the session. SEC filings show CEO Brian Shepherd and CFO Hai Tran received restricted stock grants dated Jan. 20. NEC’s $2.89 billion acquisition awaits shareholder and regulatory approval.
23 January 2026
··
Record defence IPO: Czech arms group CSG jumps as much as 32% in Amsterdam debut

Record defence IPO: Czech arms group CSG jumps as much as 32% in Amsterdam debut

Czechoslovak Group (CSG) shares jumped as much as 32% in their Amsterdam debut after pricing at 25 euros, following a record 3.3 billion euro IPO. The offering valued CSG at 25 billion euros and could reach 3.8 billion euros if the over-allotment is used. By 0812 GMT, shares traded at 30.235 euros, up 20.9%. BlackRock, Artisan Partners, and Al-Rayyan Holdings each committed 300 million euros as cornerstone investors.
23 January 2026
···
Direct Digital Holdings stock price jumps 71% in premarket as DRCT rally puts Nasdaq deadline back in focus

Direct Digital Holdings stock price jumps 71% in premarket as DRCT rally puts Nasdaq deadline back in focus

Direct Digital Holdings shares jumped 71% to $3.95 in premarket trading Friday after a 30% gain Thursday. The surge follows a 55-for-1 reverse stock split that cut the Class A share count to about 1.3 million. Nasdaq’s Jan. 30 deadline for the $1 minimum bid price rule still threatens delisting. Trading volume Thursday reached nearly 12 million shares.
23 January 2026
··
Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

Regencell Bioscience stock price jumps again: RGC up 16% premarket after 40% surge

Regencell Bioscience shares jumped 16.3% to $35.77 in premarket trading Friday after a 40.4% surge Thursday, with no new company announcements. Thursday’s rally saw heavy volume and wide price swings, closing at $30.77. The company’s filings warn of “extreme price and volume fluctuations” and note it has no saleable products or revenue. Market cap reached about $15.2 billion as of Friday.
23 January 2026
··
Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap

Novo Nordisk stock price jumps before the bell as Wegovy pill prescriptions leap

Novo Nordisk shares rose 4.9% to $62.23 in premarket trading after new data showed U.S. prescriptions for the oral Wegovy pill jumped to 20,392 from 4,286. The surge comes as investors watch prescription trends ahead of Novo’s Feb. 4 results. Rival Eli Lilly shares edged up 0.8%. India’s Sun Pharmaceutical won approval to produce generic semaglutide after the patent expires in March.
23 January 2026
·
Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical stock jumps premarket after earnings beat, but 2026 tariff hit gets attention

Intuitive Surgical shares jumped 3.6% premarket to $545 after beating fourth-quarter estimates and reporting an 18% rise in global procedures. The company forecast slower 2026 procedure growth of 13%–15% and said tariffs would cut margins by about 1.2% of revenue. Traders are watching for analyst updates at the open. Cash and investments totaled $9.03 billion at year-end.
23 January 2026
··
1 … 218 219 220 221 222 … 1,170

Stock Market Today

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

SK hynix stock price slips into Monday after S&P upgrade, tech selloff

7 February 2026
SK hynix shares closed at 839,000 won, down 0.36% Friday and 8% for the week, as tech stocks retreated across Asia. S&P Global Ratings upgraded the chipmaker to “BBB+” with a positive outlook, citing strong HBM sales. The KOSPI fell 1.4% Friday, ending a six-week winning streak. Traders await Monday’s Seoul open for signs of further tech weakness.
Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

Bank of America stock jumps 3% into the weekend — what to watch before Monday’s trade

7 February 2026
Bank of America shares rose 2.89% Friday to $56.53, tracking a rally in U.S. financial stocks as the Dow closed above 50,000. The bank will redeem its Series DD preferred stock and related depositary shares on March 10 at $1,000 per share. CEO Brian Moynihan donated 100,000 shares on Feb. 4, a regulatory filing showed. Key U.S. jobs and inflation data are due next week after delays.
Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

Oracle stock rebounds from eight-day skid as $20 billion share-sale plan looms

7 February 2026
Oracle shares jumped 4.65% to $142.82 Friday, ending an eight-day slide but remaining down 22% since Jan. 27. The company has set up a $20 billion at-the-market stock program and completed a $25 billion senior notes sale to fund cloud expansion. Oracle’s liabilities stood at $174.5 billion as of Nov. 30, 2025, before the new financing. Investors remain focused on dilution risks and the pace of capacity growth.
ASML stock price snaps back as AI spending bets return, with ex-dividend date next

ASML stock price snaps back as AI spending bets return, with ex-dividend date next

7 February 2026
ASML shares rose 3.84% Friday in Amsterdam to 1,193.80 euros, rebounding with global chip stocks after Amazon signaled a sharp increase in AI-related capital spending. The stock goes ex-dividend Feb. 9 ahead of a 1.60-euro interim payout. ASML’s Nasdaq shares climbed 4.64% to $1,413.01. Despite Friday’s gains, the Amsterdam listing finished the week about 2.5% lower.
Go toTop